The medical marijuana two-step
As attorneys and bureaucrats argue over the process, we're still no closer to getting medical marijuana into the hands of patients.
Medical Marijuana
Opinion
Opinion
Follow this topic to stay updated on recent posts.
See recent postsFor delays in medical marijuana process, blame the appropriate people
The delays in medical marijuana availability aren't because of lawsuits, but the violations of laws those lawsuits target.
Opinion
Opinion
Follow this topic to stay updated on recent posts.
See recent postsThe Alabama Cannabis Commission is not a victim
AMCC director John McMillan tried to paint his commission as a victim of frivolous lawsuits, but such a characterization defies logic and the truth.
Biden administration takes a new look at marijuana classification
Marijuana could soon be considered less dangerous in the eyes of the federal government.
Opinion
Opinion
Follow this topic to stay updated on recent posts.
See recent postsLatest medical marijuana legislation might just fix the whole process
A new bill from Sen. Tim Melson could fix the troubled medical marijuana licensing by doing the most basic thing: following the law.
Medical marijuana “fix” has rough debut in committee
The new legislation was met with skepticism and anger during a committee meeting that wasn't streamed or recorded.
The legislative “fix” for medical cannabis doesn’t appear to fix anything
The goal of a new medical weed bill is to "get the commission out of court," and it's not clear the bill does that.
A legislative “fix” in the works for Alabama’s beleaguered medical cannabis licensing
Legislation would expand the number of integrated licenses from five to as many as 15, ending many of the lawsuits currently facing the AMCC.
More legal delays in Alabama’s medical marijuana process
It will be at least late April before companies can start production, and even that seems unlikely.
Lawsuit filed to force AMCC commissioner to sit for discovery
Central to this legal face-off is the Commission's licensing process, which has been under scrutiny for months.